Promoter hypermethylation as a reversible mechanism of resistance to GPRC5D-directed therapy in multiple myeloma

Haematologica 2026 Open access

Read full text
Authors: Seungbin Han, Umair Munawar, Marietta S. Truger, Elena Hartmann, Christina Verbruggen, Leila Pfeiffer, Ann-Sophie Hainold, Shilpa Kurian, Silvia Nerreter, Emma Besant, Cornelia Vogt, Nina Rein
+12 more Max Köppel, Johanna Lehmann, Fabian Schmitt, Yoko Tamamushi, Xiang Zhou, Torsten Steinbrunn, Claudia Haferlach, Andreas Rosenwald, Hermann Einsele, Leo Rasche, Johannes Moritz Waldschmidt, Martin K. Kortüm
DOI: 10.3324/haematol.2025.289162
Cited by: 1

Fields of Study & Subjects

Multiple Myeloma Research and Treatments Epigenetics and DNA Methylation PI3K/AKT/mTOR signaling in cancer

Publication details

Journal / source
Haematologica
Publisher
Ferrata Storti Foundation (Haematologica)
Volume
111
Issue
6
Pages
2145–2148
Publication date
8 January 2026
Language
EN